Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Non-cash Items: 2012-2024

Historic Non-cash Items for Gyre Therapeutics (GYRE) over the last 12 years, with Dec 2024 value amounting to $17.5 million.

  • Gyre Therapeutics' Non-cash Items fell 11.67% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year decrease of 11.67%. This contributed to the annual value of $17.5 million for FY2024, which is 4.40% down from last year.
  • Gyre Therapeutics' Non-cash Items amounted to $17.5 million in FY2024, which was down 4.40% from $18.3 million recorded in FY2023.
  • In the past 5 years, Gyre Therapeutics' Non-cash Items registered a high of $18.3 million during FY2023, and its lowest value of $1.1 million during FY2020.
  • Over the past 3 years, Gyre Therapeutics' median Non-cash Items value was $17.5 million (recorded in 2024), while the average stood at $13.3 million.
  • Per our database at Business Quant, Gyre Therapeutics' Non-cash Items soared by 323.03% in 2023 and then dropped by 4.40% in 2024.
  • Yearly analysis of 5 years shows Gyre Therapeutics' Non-cash Items stood at $1.1 million in 2020, then spiked by 35.85% to $1.5 million in 2021, then surged by 185.32% to $4.3 million in 2022, then skyrocketed by 323.03% to $18.3 million in 2023, then fell by 4.40% to $17.5 million in 2024.